AERT Q1 2026 Earnings A Modest Profit Amidst Limited Disclosure Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline TELO Q4 2025 Earnings EPS Misses Estimates by 292 as Cash Burn Continues No Revenue Reported CRNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Management and Pipeline Progress Biglari Holdings BH Q1 2025 Earnings Strong EPS Amid Quiet Market Reception BBW Q1 2026 Earnings EPS Beats Estimates by 226 Amid Mixed Market Sentiment